144 related articles for article (PubMed ID: 23208052)
1. [Development of transcutaneous vaccination system for infectious disease countermeasure].
Matsuo K
Yakugaku Zasshi; 2012; 132(12):1443-50. PubMed ID: 23208052
[TBL] [Abstract][Full Text] [Related]
2. [Development of transcutaneous vaccine formulations for the infectious disease countermeasure].
Matsuo K; Okada N; Nakagawa S
Nihon Rinsho; 2011 Sep; 69(9):1561-6. PubMed ID: 21922753
[TBL] [Abstract][Full Text] [Related]
3. [From basic principles to clinical applications on transcutaneous vaccine].
Okada N
Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
[TBL] [Abstract][Full Text] [Related]
4. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
5. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
6. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
7. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection.
Ishii Y; Nakae T; Sakamoto F; Matsuo K; Matsuo K; Quan YS; Kamiyama F; Fujita T; Yamamoto A; Nakagawa S; Okada N
J Control Release; 2008 Oct; 131(2):113-20. PubMed ID: 18700159
[TBL] [Abstract][Full Text] [Related]
8. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
9. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
11. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
[TBL] [Abstract][Full Text] [Related]
12. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
13. Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation.
Matsuo K; Ishii Y; Kawai Y; Saiba Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Pharm Sci; 2013 Jun; 102(6):1936-1947. PubMed ID: 23585300
[TBL] [Abstract][Full Text] [Related]
14. Dissolving microneedle vaccine delivery systems.
Park K
J Control Release; 2016 Mar; 225():314. PubMed ID: 26919809
[No Abstract] [Full Text] [Related]
15. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
16. [Development of an Immune Regulation Technology Targeting the Skin and Promotion of the Practical Applications of Transcutaneous Vaccination/Immunotherapy].
Okada N
Yakugaku Zasshi; 2019; 139(9):1129-1137. PubMed ID: 31474627
[TBL] [Abstract][Full Text] [Related]
17. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.
Hegde NR; Kaveri SV; Bayry J
Drug Discov Today; 2011 Dec; 16(23-24):1061-8. PubMed ID: 21782969
[TBL] [Abstract][Full Text] [Related]
19. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
